UOC
CBAY icon

UBS O'Connor’s Cymabay Therapeutics CBAY Stock Holding History

UBS O'Connor’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40,000
Closed -$531K – 303
2019
Q1 		$531K Buy
+40,000
New +$425K 0.01% 197

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

UBS O'Connor's CBAY Position: Q2 2019 in Review

UBS O'Connor sold out of Cymabay Therapeutics (CBAY) in Q2 2019, closing a stake of 40,000 shares — an estimated $531K sold.

UBS O'Connor first reported a position in CBAY in Q1 2019 and held it in 1 quarter. The position peaked at $531K in Q1 2019. 133 funds tracked by Wall St. Rank hold CBAY as of Q2 2019.

  • UBS O'Connor reported no remaining Cymabay Therapeutics position as of Q2 2019 after selling out during the quarter.
  • UBS O'Connor sold 40,000 Cymabay Therapeutics shares in Q2 2019, an estimated $531K.
  • UBS O'Connor first reported a position in Cymabay Therapeutics in Q1 2019 and held it in 1 quarter.
  • UBS O'Connor's Cymabay Therapeutics position peaked at $531K in Q1 2019.
  • 133 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2019.

Based on UBS O'Connor's 13F filing for Q2 2019, filed 14 Aug 2019.